(VIANEWS) – Shares of Merrimack Pharmaceuticals (NASDAQ Composite: MACK) dropped 7.13% to $4.30 at 16:17 EST on Monday, after three successive sessions in a row of losses. NASDAQ Composite is sliding 2.19% to $14,713.90, after five sequential sessions in a row of losses. This seems, up until now, an all-around down trend exchanging session today.
Merrimack Pharmaceuticals’s last close was $4.79, 49.31% under its 52-week high of $9.45.
Today’s last reported volume for Merrimack Pharmaceuticals is 13771 which is 35.05% below its average volume of 21204.
Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value
Merrimack Pharmaceuticals’s stock is valued at $4.30 at 16:17 EST, way under its 52-week high of $9.45 and way higher than its 52-week low of $3.56.
Merrimack Pharmaceuticals’s Moving Average
Merrimack Pharmaceuticals’s worth is way under its 50-day moving average of $4.85 and way below its 200-day moving average of $6.12.
More news about Merrimack Pharmaceuticals (MACK).